OneCell Diagnostics is now 1Cell.Ai

Contact

India

  • Featured
  • India

1Cell ERA Newsletter | July 2026

The July 2026 edition of the 1Cell.Ai Newsletter explores a pivotal moment in precision oncology, when emerging evidence becomes clinical practice. This issue unpacks the latest NCCN Bladder Cancer guideline update endorsing ctDNA-based minimal residual disease (MRD) testing for treatment...
  • 2 mins read
Read Newsletter
  • Featured
  • India

Analytical Validation and Clinical Implementation of a 1080-Gene Comprehensive Genomic Profiling Assay with Integrated Cloud-Based Analysis for Solid Tumor Molecular Oncology 

The Problem With Small Panels  Precision oncology depends on knowing the full genomic landscape of a patient’s tumour. Yet most clinical laboratories continue to rely on gene panels covering only 50 to 100 genes– panels that routinely miss critical hotspots, emerging driver mutations, and pan-tumour...
  • 3 mins read
Read Article
  • Featured
  • India

1Cell ERA Newsletter | June 2026

ASCO 2026 delivered a defining moment for precision oncology, and the 1Cell.Ai June 2026 Edition Newsletter captures why. From landmark trial data reshaping treatment sequencing to a deeper understanding of how tumours evolve resistance in real time, this month’s research...
  • 2 mins read
Read Newsletter

Filters

Cancer Type

Test Type

Use Case

Biomarkers/Mutations

Loading...
Close
1Cell.Ai
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.